Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.41 by 31.71 percent. This is a 31.71 percent increase over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $391.918 million which beat the analyst consensus estimate of $381.870 million by 2.63 percent. This is a 2.42 percent increase over sales of $382.653 million the same period last year.